Analysis of 19,000 cancer samples from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) revealed mutations in RPL5 and RPL11 in 139 and 74 cases, respectively, indicating their involvement in cancer pathogenesis [122]. This evidence concerns the gene RPL11 and cancer.